한국형 양극성 장애 약물치료 알고리듬 2022: 총론 = Korean Medication Algorithm Project for Bipolar Disorder 2022: Overview

다국어 초록 (Multilingual Abstract)

Objectives The pharmacotherapy of bipolar disorder is complex. A treatment guideline or algorithm can help clinicians implement better practices and clinical decisions. Therefore, the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was revised through expert consensus on pharmacotherapy for bipolar disorder.
Methods We revised the KMAP-BP 2018 questionnaire and conducted a survey of expert clinicians.
Out of ninety-three members of the review committee, eighty-seven completed the survey.
We analyzed the answers, discussed the data, and held a clinician hearing. Here, we report the results from KMAP-BP 2022.
Results The preferred first-step strategies for acute euphoric mania are a combination of a mood stabilizer (MS) and an atypical antipsychotic (AAP), MS monotherapy, and AAP monotherapy.
For psychotic mania, an MS and AAP combination, and AAP monotherapy are preferred.
For hypomania, MS monotherapy and AAP monotherapy are preferred. The first-step strategies for mild to moderate bipolar depression are MS monotherapy, lamotrigine (LMT) monotherapy, AAP monotherapy, an MS+AAP combination, and an AAP+LMT combination. For non-psychotic severe depression, the MS+AAP combination, the AAP+LMT combination, and the MS+LMT combination are preferred. For psychotic severe depression, MS+AAP and AAP+LMT are preferred.
Conclusion We obtained expert consensus and developed KMAP-BP 2022. Compared with KMAP-BP 2018, we can figure out clinicians’ preferences and decisions in real clinical situations more clearly. The preference for AAP increased, and that of MS and an antidepressant decreased.
We hope KMAP-BP 2022 is helpful for clinicians who treat patients with bipolar disorder.

참고문헌 (Reference)

1 전덕인 ; 박원명 ; 신영철 ; 김찬형 ; 민경준 ; 윤보현 ; 김영기 ; 권준수 ; 조현상, "한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(Ⅲ)：치료반응과 내약성" 대한정신약물학회 16 (16): 292-300, 2005

2 신영철 ; 박원명 ; 김찬형 ; 민경준 ; 윤보현 ; 조현상 ; 권준수 ; 전덕인, "한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(Ⅱ)：약물의 선택" 대한정신약물학회 16 (16): 285-291, 2005

3 김찬형 ; 민경준 ; 신영철 ; 윤보현 ; 조현상 ; 전덕인 ; 김영기 ; 권준수 ; 박원명, "한국형 양극성 장애 약물치료 알고리듬의 적용 가능성(Ⅰ)：전반적 평가" 대한정신약물학회 16 (16): 225-233, 2005

4 민경준 ; 박원명 ; 윤보현 ; 김원 ; 김병수 ; 이정구 ; 주연호 ; 서정석 ; 이은 ; 안용민 ; 신영철 ; 우영섭 ; 전덕인, "한국형 양극성 장애 약물치료 알고리듬 2010: 총론" 대한정신약물학회 22 (22): 142-153, 2011

5 윤보현 ; 박원명 ; 민경준 ; 김원 ; 김병수 ; 이정구 ; 주연호 ; 서정석 ; 이은 ; 안용민 ; 신영철 ; 우영섭 ; 배승오 ; 전덕인, "한국형 양극성 장애 약물치료 알고리듬 2010: 다른 치료 지침들과의 비교" 대한정신약물학회 22 (22): 171-182, 2011

6 박원명 ; 신영철 ; 전덕인 ; 윤보현 ; 김대진 ; 안용민 ; 권준수 ; 민경준, "양극성 장애의 한국형 약물치료 알고리듬" 대한정신약물학회 13 (13): 205-221, 2002

7 McIntyre JS, "Usefulness and limitations of treatment guidelines in psychiatry" 1 : 186-189, 2002

8 Parmentier T, "The use of triiodothyronine (T3) in the treatment of bipolar depression: a review of the literature" 229 : 410-414, 2018

9 Judd LL, "The long-term natural history of the weekly symptomatic status of bipolar I disorder" 59 : 530-537, 2002

10 Sachs GS, "The expert consensus guideline series: medication treatment of bipolar disorder 2000" 1-104, 2000

11 Solmi M, "Safety, tolerability, and risks associated with first- and secondgeneration antipsychotics: a state-of-the-art clinical review" 13 : 757-777, 2017

12 Jon DI, "Revised Korean medication algorithm for bipolar disorder" 10 (10): 846-855, 2009

13 Suttajit S, "Quetiapine for acute bipolar depression : a systematic review and meta-analysis" 8 : 827-838, 2014

14 Candy M, "Psychostimulants for depression" 2 : CD006722-, 2008

15 Zagozdzon P, "Mortality rates in users of typical and atypical antipsychotics : a database study in Poland" 3 : 345-351, 2016

16 Solmi M, "Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in shortterm trials" 21 : 403-418, 2016

17 Woo YS, "Korean medication algorithm project for bipolar disorder : third revision" 11 : 493-506, 2015

18 Shin YC, "Korean medication algorithm for bipolar disorder : second revision" 5 : 301-308, 2013

19 Jeong Seok Seo ; Won-Myong Bahk ; Hee Ryung Wang ; Young Sup Woo ; Young-Min Park ; Jong Hyun Jeong ; Won Kim ; Se-Hoon Shim ; Jung Goo Lee ; Duk-In Jon ; Kyung Joon Min, "Korean Medication Algorithm for Depressive Disorders 2017: Third Revision" 대한정신약물학회 16 (16): 67-87, 2018

20 Young Sup Woo ; Won-Myong Bahk ; Jung Goo Lee ; Jong Hyun Jeong ; Moon Doo Kim ; Inki Sohn ; Se-Hoon Shim ; Duk-In Jon ; Jeong Seok Seo ; Kyung Joon Min ; Won Kim ; 송후림 ; Bo-Hyun Yoon, "Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision" 대한정신약물학회 16 (16): 434-448, 2018

21 Goodwin GM, "Evidence-based guidelines for treating bipolar disorder:revised third edition recommendations from the British Association for Psychopharmacology" 30 : 495-553, 2016

22 Bartoli F, "Effect of clinical response to active drugs and placebo on antipsychotics and mood stabilizers relative efficacy for bipolar depression and mania:a meta-regression analysis" 32 : 416-422, 2018

23 Culleton B, "Development and limitations of clinical practice guidelines" 473 : 251-261, 2009

24 Song HR, "Current prescription pattern of maintenance treatments for bipolar patients in Korea : a focus on the transition from acute treatments" 70 : 42-50, 2016

25 Cipriani A, "Comparative efficacy and acceptability of antimanic drugs in acute mania : a multiple-treatments meta-analysis" 378 : 1306-1315, 2011

26 McGirr A, "Clinical efficacy and safety of repetitive transcranial magnetic stimulation in acute bipolar depression" 15 : 85-86, 2016

27 Yatham LN, "Canadian network for mood and anxiety treatments (CANMAT)and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013" 15 : 1-44, 2013

28 Kennedy SH, "Canadian network for mood and anxiety treatments (CANMAT)2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments" 61 : 540-560, 2016

29 National Institute for Health and Care Excellence, "Bipolar disorder: assessment and management. Clinical guideline [CG185]"

30 El-Mallakh RS, "Antidepressants worsen rapid-cycling course in bipolar depression : a STEP-BD randomized clinical trial" 184 : 318-321, 2015

31 Yildiz A, "A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania" 45 : 299-317, 2015